What is the target ferritin level for treating iron‑deficiency anemia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 29, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Target Ferritin Level for Iron-Deficiency Anemia

For general IDA without chronic kidney disease, target a serum ferritin of at least 30-45 ng/mL (67.4-89.9 pmol/L) to optimize hemoglobin response, though higher targets of 100 ng/mL may be needed in patients with inflammation or those on erythropoiesis-stimulating agents.

Context-Specific Ferritin Targets

Non-CKD Patients (General Population)

The target ferritin varies based on clinical context:

  • Minimum threshold: 30-45 ng/mL is the evidence-based lower limit for adequate iron stores 1, 2
  • Optimal range for treatment response: 30-40 ng/mL (67.4-89.9 pmol/L) correlates with achieving target hemoglobin of 120-130 g/L in patients with minor inflammation 3
  • With inflammation present: Target ferritin >100 ng/mL, as ferritin is an acute phase reactant and "normal" levels may mask true iron deficiency 4

CKD and Hemodialysis Patients

The targets are substantially higher in CKD due to functional iron deficiency and ESA use:

  • Minimum target: Maintain ferritin ≥100 ng/mL and TSAT ≥20% 5
  • Optimal target for hemodialysis: Ferritin >200 ng/mL provides better anemia correction at lower ESA doses 6
  • Upper safety limit: Withhold IV iron when ferritin >800 ng/mL or TSAT >50% 5
  • Caution zone: Evidence for IV iron safety when ferritin >500 ng/mL is limited 7, 6

Clinical Decision Algorithm

Step 1: Identify patient population

  • General IDA → Target 30-100 ng/mL
  • CKD/HD on ESA → Target 100-500 ng/mL (ideally >200 ng/mL)
  • Inflammatory conditions → Target >100 ng/mL

Step 2: Monitor treatment response

  • Check hemoglobin at 2-4 weeks for oral iron 2
  • Reassess ferritin every 3 months in CKD patients 5
  • If ferritin adequate but hemoglobin suboptimal, consider functional iron deficiency (check TSAT)

Step 3: Adjust therapy route

  • Oral iron first-line for most patients 1, 2
  • Switch to IV iron if: oral intolerance, inadequate response after 2-4 weeks, active inflammation with malabsorption, or CKD on hemodialysis 5, 1

Important Caveats

Ferritin interpretation pitfalls:

  • Ferritin <15 ng/mL is highly specific (99%) for iron deficiency 4
  • Ferritin 15-100 ng/mL in inflammatory states may still represent iron deficiency—use TSAT <20% as confirmatory test 4
  • A ferritin >150 ng/mL makes absolute iron deficiency unlikely even with inflammation 4

Upper limit concerns: The 2008 KDIGO guidelines 6 demonstrated that even patients with ferritin 500-1200 ng/mL and TSAT <25% showed hemoglobin improvement with IV iron, though long-term safety data remain limited. Exercise caution when ferritin exceeds 500 ng/mL unless TSAT remains low and anemia persists despite adequate ESA dosing.

Route-specific considerations: Every-other-day oral iron dosing improves absorption compared to daily dosing 2. For IV iron in hemodialysis, maintenance doses of 25-125 mg/week typically maintain target ferritin once achieved 5.

The goal is hemoglobin optimization and symptom resolution, not achieving arbitrary ferritin numbers—ferritin serves as a guide to ensure adequate iron availability for erythropoiesis 5.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.